Patents by Inventor Joshua Hansen

Joshua Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190361005
    Abstract: A method of identifying a subject having cancer who is likely to be responsive to a treatment compound, comprising administering the treatment compound to the subject having the cancer; obtaining a sample from the subject; determining the level of a biomarker in the sample from the subject; and diagnosing the subject as being likely to be responsive to the treatment compound if the level of the biomarker in the sample of the subject changes as compared to a reference level of the biomarker; wherein the treatment compound is Compound 1, Compound 2, or Compound 3.
    Type: Application
    Filed: May 22, 2019
    Publication date: November 28, 2019
    Inventors: Maria Soraya Carrancio Anton, Joshua Hansen, Courtney G. Havens, Antonia Lopez-Girona, Gang Lu, Daniel W. Pierce, Lilly L. Wong
  • Publication number: 20190336507
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Application
    Filed: July 17, 2019
    Publication date: November 7, 2019
    Inventors: Matthew Alexander, Joshua Hansen, Dehua Huang, Robert Hubbard, Raj K. Raheja, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, JingJing Zhao, Shuichan Xu, Sogole Bahmanyar
  • Publication number: 20190322647
    Abstract: Provided herein are 4-aminoisoindoline-1,3-dione compounds having the following structure: wherein R, Ring A, and n are as defined herein, compositions comprising an effective amount of a 4-aminoisoindoline-1,3-dione compound, and methods for treating or preventing disorders.
    Type: Application
    Filed: April 22, 2019
    Publication date: October 24, 2019
    Inventors: Matthew D. Alexander, Soraya Carrancio, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen, Roy L. Harris, Dehua Huang, Timothy S. Kercher, Antonia Lopez-Girona, Mark A. Nagy, Veronique Plantevin-Krenitsky
  • Publication number: 20190282567
    Abstract: Provided herein is 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof, and methods for treating, preventing or managing multiple myeloma using such compounds. Also provided are pharmaceutical compositions comprising the compounds, and methods of use of the compositions.
    Type: Application
    Filed: June 3, 2019
    Publication date: September 19, 2019
    Inventors: Matthew D. Alexander, Gerald D. Artman, III, Gordon L. Bray, James Carmichael, Soraya Carrancio, Brian E. Cathers, Matthew D. Correa, Joshua Hansen, Courtney G. Havens, Timothy S. Kercher, Antonia Lopez-Girona, Xiaoling Lu, Hon-Wah Man, Mark A. Nagy, Rama K. Narla, Joseph R. Piccotti, Daniel W. Pierce, Paula A. Tavares-Greco, Brandon W. Whitefield, Lilly L. Wong, Nanfei Zou
  • Publication number: 20190275411
    Abstract: The object of the invention is to provide a system that will allow multiple participants in remote locations to participate in a board game. The disclosure presented herein relates to a remote gameplay platform. Multiple instances of the platform may be combined to form a platform network, or a platform may be combined with virtual instances of the platform that would allow remote users to physically manipulate the board from remote locations.
    Type: Application
    Filed: March 11, 2019
    Publication date: September 12, 2019
    Inventors: Miranda Hansen, Joshua Cummings, John Barth
  • Patent number: 10410258
    Abstract: According to various aspects of the present invention, a user interface capable of effectively manipulating high volumes of data is provided. The system and/or user interface is specially configured to aggregate large data volumes and translate the large data volumes into summary information and incorporate navigable categorizations that enable dynamic selection and visualization of portions of the large data volumes. Such interfaces may be particularly useful for managing large amounts of information, such as ad placement and performance information that is generated within an advertising network associated with ad campaigns. Moreover the integration of such summary menus in detailed visualizations improves information access, limits rendering operations by the system, and enables more efficient retrieval and visualization of information. In some examples, the contextual views limit errors in data entry, for example, by providing contextual visualization for subsequent functions.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: September 10, 2019
    Assignee: Nanigans, Inc.
    Inventors: Claude Denton, Ric Calvillo, Joshua Allen Breckman, Travis Hansen, Jonathan Palmer, George Plesko, Keith Wright
  • Patent number: 10398700
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: September 3, 2019
    Assignee: Signal Pharmaceuticals, LLC
    Inventors: Matthew Alexander, Joshua Hansen, Dehua Huang, Robert Hubbard, Raj K. Raheja, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, JingJing Zhao
  • Patent number: 10392398
    Abstract: The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formula (I)-(XXVI) and (III?) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: August 27, 2019
    Assignee: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Ulla Hansen, Scott Schaus, Trevor Grant, Joshua Bishop, John Kavouris, Lisa M. Christadore
  • Publication number: 20190235920
    Abstract: A computer-implemented method is disclosed. The method comprises receiving a notification from a job scheduler that an execution time for a job registered with the job scheduler is at or before a first time being a current time. The method also comprises identifying, in response to receiving the notification, at least one task from a task data structure with a target runtime that is at or before the first time. The task data structure stores task data for one or more tasks received from one or more client computers, and the task data associates each of the one or more tasks with a target runtime. The method further comprises initiating execution for each of the at least one task and determining whether there is a specific task from the task data structure with a specific target runtime after the first time.
    Type: Application
    Filed: April 9, 2019
    Publication date: August 1, 2019
    Applicant: ATLASSIAN PTY LTD
    Inventors: Brad BAKER, Michael RUFLIN, Joshua HANSEN, Adam HYNES, Clément CAPIAUX, Edward ZHANG
  • Patent number: 10357489
    Abstract: Provided herein is 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof, and methods for treating, preventing or managing multiple myeloma using such compounds. Also provided are pharmaceutical compositions comprising the compounds, and methods of use of the compositions.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: July 23, 2019
    Assignee: Celgene Corporation
    Inventors: Matthew D. Alexander, Gerald D. Artman, III, James Carmichael, Brian E. Cathers, Matthew D. Correa, Joshua Hansen, Courtney G. Havens, Timothy S. Kercher, Antonia Lopez-Girona, Xiaoling Lu, Hon-Wah Man, Mark A. Nagy, Joseph R. Piccotti, Daniel W. Pierce, Paula A. Tavares-Greco, Brandon W. Whitefield, Lilly L. Wong, Nanfei Zou
  • Patent number: 10303512
    Abstract: Disclosed herein is a computer implemented method for scheduling a new task. The method comprises: receiving task data in respect of the new task, the task data comprising at least information enabling the new task to be uniquely identified and a target runtime for the new task; recording the received task data in a data structure and determining if a new job needs to be registered with an underlying job scheduler.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: May 28, 2019
    Assignee: Atlassian Pty Ltd
    Inventors: Brad Baker, Michael Ruflin, Joshua Hansen, Adam Hynes, Clement Capiaux, Edward Zhang
  • Publication number: 20190152942
    Abstract: Compounds of formula A-I and B-I, compositions comprising the compounds, methods of making the compounds and methods of their uses are disclosed.
    Type: Application
    Filed: January 22, 2019
    Publication date: May 23, 2019
    Inventors: Matthew D. Alexander, Matthew D. Correa, Joshua Hansen, Raj Kumar Raheja, John Sapienza
  • Patent number: 10291616
    Abstract: A resource authorization system includes an authorization routing service that is executed on a computing device to authenticate a client to form a client login session, and to receive, from the client, a request to establish a connection to one or more of the resources of a distributed computing system. The authorization routing service then obtains a list of the resources associated with the client login session in which the list of resources includes those that the client is authorized to communicate with. When the requested resource is included in the list of resources, the authorization routing service authenticates the requested resources to form a resource login session, and establish the connection by communicatively coupling the client login session and the resource login session. The resource login session is established independently of the client login session.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: May 14, 2019
    Assignee: VCE IP Holding Company LLC
    Inventors: Jonathan P. Streete, Joshua L. Bonczkowski, Nicholas A. Hansen
  • Publication number: 20190091230
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Application
    Filed: October 24, 2018
    Publication date: March 28, 2019
    Inventors: Matthew Alexander, Joshua Hansen, Dehua Huang, Robert Hubbard, Raj K. Raheja, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, JingJing Zhao
  • Patent number: 10227325
    Abstract: Compounds of formula A-I and B-I, compositions comprising the compounds, methods of making the compounds and methods of their uses are disclosed.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: March 12, 2019
    Assignee: Celgene Corporation
    Inventors: Matthew D. Alexander, Matthew D. Correa, Joshua Hansen, Raj Kumar Raheja, John Sapienza
  • Publication number: 20190008852
    Abstract: Provided herein is 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof, and methods for treating, preventing or managing multiple myeloma using such compounds. Also provided are pharmaceutical compositions comprising the compounds, and methods of use of the compositions.
    Type: Application
    Filed: July 9, 2018
    Publication date: January 10, 2019
    Inventors: Matthew D. Alexander, Gerald D. Artman, III, Gordon L. Bray, James Carmichael, Soraya Carrancio, Brian E. Cathers, Matthew D. Correa, Joshua Hansen, Courtney G. Havens, Timothy S. Kercher, Antonia Lopez-Girona, Xiaoling Lu, Hon-Wah Man, Mark A. Nagy, Rama K. Narla, Joseph R. Piccotti, Daniel W. Pierce, Paula A. Tavares-Greco, Brandon W. Whitefield, Lilly L. Wong, Nanfei Zou
  • Patent number: 10149849
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: December 11, 2018
    Assignee: Signal Pharmaceuticals, LLC
    Inventors: Matthew Alexander, Joshua Hansen, Dehua Huang, Robert Hubbard, Raj K. Raheja, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, JingJing Zhao
  • Publication number: 20180221361
    Abstract: Compounds of formula I for treating, preventing or managing cancer are disclosed. Also disclosed are methods of treating, preventing or managing cancer, such as leukemia, comprising administering the compounds. In certain embodiments, the method of treatment comprise administering a compound provided herein in combination with a second agent. Pharmaceutical compositions and single unit dosage forms comprising the compounds are also disclosed.
    Type: Application
    Filed: April 9, 2018
    Publication date: August 9, 2018
    Inventors: Brian E. Cathers, Matthew Daniel Correa, Joshua Hansen, Antonia Lopez-Girona, Ehab M. Khalil, Kyle MacBeth, Hon-Wah Man, George W. Muller, Michael Pourdehnad, Raj Raheja
  • Publication number: 20180186767
    Abstract: Compounds of formula A-I and B-I, compositions comprising the compounds, methods of making the compounds and methods of their uses are disclosed.
    Type: Application
    Filed: February 28, 2018
    Publication date: July 5, 2018
    Inventors: Matthew D. Alexander, Matthew D. Correa, Joshua Hansen, Raj Kumar Raheja, John Sapienza
  • Patent number: 9968596
    Abstract: Compounds of formula I for treating, preventing or managing cancer are disclosed. Also disclosed are methods of treating, preventing or managing cancer, such as leukemia, comprising administering the compounds. In certain embodiments, the method of treatment comprise administering a compound provided herein in combination with a second agent. Pharmaceutical compositions and single unit dosage forms comprising the compounds are also disclosed.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: May 15, 2018
    Assignee: Celgene Corporation
    Inventors: Brian E. Cathers, Matthew Daniel Correa, Joshua Hansen, Antonia Lopez-Girona, Ehab M. Khalil, Kyle MacBeth, Hon-Wah Man, George W. Muller, Michael Pourdehnad, Raj Raheja